A multi-center, double-blind, randomized, placebo-controlled, parallel design study to evaluate the efficacy and safety of intravenous tedisamil sesquifumarate in the rapid conversion to normal sinus rhythm in female subjects with recent onset atrial fibrillation or flutter.

Trial Profile

A multi-center, double-blind, randomized, placebo-controlled, parallel design study to evaluate the efficacy and safety of intravenous tedisamil sesquifumarate in the rapid conversion to normal sinus rhythm in female subjects with recent onset atrial fibrillation or flutter.

Completed
Phase of Trial: Phase III

Latest Information Update: 20 Jan 2015

At a glance

  • Drugs Tedisamil (Primary)
  • Indications Atrial fibrillation; Atrial flutter
  • Focus Pharmacokinetics; Registrational; Therapeutic Use
  • Most Recent Events

    • 20 Jan 2015 Last checked against European Clinical Trials Database
    • 20 Apr 2010 Additional trial locations (USA, Italy and Germany) added as reported by ClinicalTrials.gov record.
    • 06 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top